Scientists in China use AI to pinpoint new therapeutic targets in PAH
WHY IT MATTERS
If ATP1B1 and HP prove to be valid therapeutic targets, they could lead to new treatment options for PAH patients who currently have limited medication choices.
Researchers in China used artificial intelligence to study the genes involved in pulmonary arterial hypertension (PAH), a serious condition where blood vessels in the lungs become narrowed and stiff. They identified two genes called ATP1B1 and HP that appear to be important in causing PAH. These genes could potentially become targets for new treatments in the future.
Using artificial intelligence (AI) and analyzing genetic data focused on two primary biochemical processes, a team of scientists in China has identified two genes that appear to play key roles in driving pulmonary arterial hypertension (PAH). Computer-based analyses suggest that these two genes, called ATP1B1 and HP, may be useful therapeutic targets in PAH — […] The post Scientists in China use AI to pinpoint new therapeutic targets in PAH appeared first on Pulmonary Hypertension News .